EBITDA

Creatv Bio will present data at ASCO 2026 on its LifeTracDx® blood test, showcasing its potential to personalize cancer treatment through key pharma partnerships.

Linea's ZK rollup stack is now Lineth, a new Linux Foundation project. The move signals a major shift towards vendor-neutral governance for Ethereum scaling.

The world's leading expert network, GLG, launches an AI-powered platform, aiming to merge machine speed with human insight for a new era of research.

The largest-ever study on school phone bans confirms huge drops in phone use and improved student well-being, but the impact on test scores is more complex.

Tunnell Consulting's perfect CMMC score reveals a cost-effective enclave strategy, challenging the belief that compliance must be an expensive overhaul.

As AI-generated content floods the internet, PeakMetrics launches advanced tools to help organizations distinguish real narratives from manipulated ones.

With a novel 'NewCo' model and key partnerships, Banyan BioInnovations aims to de-risk and accelerate clinical-stage drugs past the funding valley of death.

A new partnership aims to tackle AI's biggest security risks, signaling a major industry shift from functional AI to production-ready, secure AI.

GMEX Robotics' first deployment of its Bon Vivant 3.0 cooking robots marks a new era for Australia's hospitality industry, blending AI with culinary arts.

Netskope's new AgentSkope platform uses AI agents to automate security tasks, aiming to solve the industry's crippling alert fatigue and analyst burnout.

JAGGAER launches JAI, an AI assistant promising to slash support tickets and automate complex buying decisions, pushing procurement toward an autonomous future.

Arctera shifts to a unified SaaS model, promising limitless scale for data compliance. What does this strategic pivot mean for enterprises and the market?

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.

Forrester's new report highlights Airia as enterprises grapple with governing the new wave of autonomous, agentic AI systems that defy old rules.

A new partnership offers employees interest-free financing for out-of-pocket medical costs, tackling a key barrier to care and boosting employer benefits.

A new all-in-one system from Sweden's Multi4 Medical just won EU approval, allowing urologists to treat bladder cancer in minutes without surgery.

From 90s trends to green innovations, Canada's top salon chain celebrates 35 years of style, sustainability, and putting its stylists first.

A historic 142 deals and $1.67 trillion in assets changed hands in Q1 2026, as private equity, tech, and global ambitions fuel a record consolidation wave.

Diagnostic leader Bracco enters the cell therapy market with BubbleGen, a novel microbubble tech that promises to streamline complex manufacturing.

The global investment bank is buying the boutique firm behind landmark deals for Liverpool FC and the NY Mets to dominate the booming sports finance market.